Aligos Therapeutics (ALGS) vs Cel-Sci (CVM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Aligos Therapeutics (ALGS) has outperformed Cel-Sci (CVM) over the past year, losing 45.9% versus a loss of 79.1%. Over five years, ALGS leads with a -98.7% price change compared with -99.3% for CVM. Cel-Sci is the larger company by market cap ($33.9 million vs $33.2 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ALGS | CVM |
|---|---|---|
| Share price | $5.31 | $1.93 |
| Market cap | $33.16M | $33.95M |
| 1-day change | -0.19% | -9.39% |
| YTD return | -42.92% | -59.51% |
| 1-year return | -45.93% | -79.12% |
| 5-year return | -98.66% | -99.32% |
| EPS (TTM) | $-7.41 | $-1.69 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $13.69 | $10.39 |
| 52-week low | $3.98 | $0.89 |
| Distance from 52-week high | -61.21% | -81.42% |
| Average volume | 91.45K | 241.50K |
| Shares outstanding | 5.44M | 17.59M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ALGS has outperformed CVM by 33.2 percentage points over the past year.
ALGS vs CVM FAQ
Which is bigger, Aligos Therapeutics or Cel-Sci?
Cel-Sci (CVM) is larger, with a market capitalization of $33.95M compared with $33.16M for Aligos Therapeutics (ALGS).
Which stock has performed better over the past year, ALGS or CVM?
ALGS returned -45.93% over the past 12 months, compared with -79.12% for CVM (price return, excluding dividends). Past performance does not predict future results.
Are Aligos Therapeutics and Cel-Sci in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.